Correlation Between Kazia Therapeutics and InMed Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kazia Therapeutics and InMed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kazia Therapeutics and InMed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kazia Therapeutics Ltd and InMed Pharmaceuticals, you can compare the effects of market volatilities on Kazia Therapeutics and InMed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kazia Therapeutics with a short position of InMed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kazia Therapeutics and InMed Pharmaceuticals.

Diversification Opportunities for Kazia Therapeutics and InMed Pharmaceuticals

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Kazia and InMed is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Kazia Therapeutics Ltd and InMed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InMed Pharmaceuticals and Kazia Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kazia Therapeutics Ltd are associated (or correlated) with InMed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InMed Pharmaceuticals has no effect on the direction of Kazia Therapeutics i.e., Kazia Therapeutics and InMed Pharmaceuticals go up and down completely randomly.

Pair Corralation between Kazia Therapeutics and InMed Pharmaceuticals

Given the investment horizon of 90 days Kazia Therapeutics Ltd is expected to generate 2.14 times more return on investment than InMed Pharmaceuticals. However, Kazia Therapeutics is 2.14 times more volatile than InMed Pharmaceuticals. It trades about 0.14 of its potential returns per unit of risk. InMed Pharmaceuticals is currently generating about -0.14 per unit of risk. If you would invest  825.00  in Kazia Therapeutics Ltd on September 10, 2025 and sell it today you would earn a total of  747.00  from holding Kazia Therapeutics Ltd or generate 90.55% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Kazia Therapeutics Ltd  vs.  InMed Pharmaceuticals

 Performance 
       Timeline  
Kazia Therapeutics 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Kazia Therapeutics Ltd are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile forward indicators, Kazia Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.
InMed Pharmaceuticals 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days InMed Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2026. The recent disarray may also be a sign of long period up-swing for the firm investors.

Kazia Therapeutics and InMed Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kazia Therapeutics and InMed Pharmaceuticals

The main advantage of trading using opposite Kazia Therapeutics and InMed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kazia Therapeutics position performs unexpectedly, InMed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InMed Pharmaceuticals will offset losses from the drop in InMed Pharmaceuticals' long position.
The idea behind Kazia Therapeutics Ltd and InMed Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities